Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
Discover the complete contamination control strategy for your company.
From the R&D phase to the clinical trials phase to the commercial production phase, partner with Ecolab to keep contamination risk under control and your operations on track.
Watch Video |Download The EBook
Cell and Gene Therapy industry provides a unique regulatory challenge to navigate. Compliance very often relies on a case by case risk assessment.
Regulation trends reflected in the recent EU GMP Annex 1 update formally recommend the use of closed systems, such as Isolators. Isolators provide a complete barrier between the process and surrounding environment, offering better in-process contamination control. The use of Isolators should be implemented early in development phase to ease transition from R&D to clinical trials and commercial manufacturing.
The development of novel Cell & Gene therapies such as CAR T-Cells, mRNA or stem cell therapy requires extended Research and Development activity before starting clinical trials. The Bioquell Qube is a standard, off-the-shelf isolator which provides a grade A/ISO 5 working environment without the need for complex integration into a building. This means no construction work, removal of cleanroom panels, no HVAC connections needed, and no additional electrical installations are needed. Due to its unique polyproylene construction, the Bioquell Qube can be delivered, installed and validated in as little as 16 weeks.
“*EPA Registration Number: 72372-1-86703”
Showcasing the Bioquell Qube’s impact in cell and gene therapy.
Case Study 1: See how this company saved hundreds of hours in productivity and cut energy costs.
Case Study 2: Discover how a company increased profitability while reducing batch failure and more.
EU GMP Annex 1 recommends that an appropriate Contamination Control Strategy (CCS) is implemented to ensure compliance and patient safety. Isolator systems can create a closed process that helps mitigate the risk of contamination during all critical aseptic operations, from genetic engineering to fill/finish.
The Bioquell Qubes modularity supports your operations, from small batch production to processes requiring multiple human interactions to regulatory and quality control needs.
Find the right setup for your process with our configuration sheet.
Learn more about Bioquell’s technology here or contact us below
To learn more about how Bioquell can fit your solution, please contact us.
Ecolab Inc
702 Electronic Dr. Suite 200
Horsham, PA 19044
+1 215 682 0225
bioquellusorders@ecolab.com
To learn more about how Bioquell can fit your solution, please contact us.
Ecolab Inc
702 Electronic Dr. Suite 200
Horsham, PA 19044
+1 215 682 0225
bioquellusorders@ecolab.com
19